ClinicalTrials.gg
Not yet recruitingNCT07405593Updated Feb 12, 2026

Head Up Position and Murottal Therapy in Stroke Patients

An interventional study of Combination of 30 Degree Head Up and Murottal Therapy and Standard Care (in control arm) in Stroke, sponsored by Universitas Muhammadiyah Surakarta. Not yet recruiting at 1 site in Indonesia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-12.

Sponsored by Universitas Muhammadiyah Surakarta · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
112
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Stroke with a site in Indonesia — 7 open to participants now, 8 under way, none of them phase 3. Stroke · Indonesia.

Planned enrollment
3rd of 10
112 · median 44
Started
2026
with 3 others
No phase
7 of 13
6 open now
Registered
10th of 13
by date
Lead sponsor
1 of 13
Universitas Muhammadiyah Surakarta

Among the 13 studies in Stroke with a site in Indonesia, this one is the 3rd largest by planned enrollment of the 10 interventional ones that give a count, is one of 4 that started in 2026, is one of 7 with no phase, and was the 10th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

7 of the 13 studies in Stroke with a site in Indonesia are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Indonesia have not opened yet or have stopped. Only those recruiting at a site in Indonesia →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Stroke with a site in Indonesia, or all of them as a file.
02

Study summary

This study aims to evaluate the effects of a combination of a 30-degree head-up position and murottal therapy on physiological and symptom outcomes in stroke patients. The intervention is expected to influence blood pressure, pulse rate, respiratory rate, pain level, and the incidence of projectile vomiting. Stroke patients will receive standard care with the addition of the combined intervention. The results of this study may support non-pharmacological nursing interventions to improve patient comfort and clinical stability.

Read the detailed description

Stroke patients often experience physiological instability and discomfort, including changes in blood pressure, pulse rate, respiratory rate, pain, and nausea or vomiting. Non-pharmacological nursing interventions are needed to support patient comfort and clinical stability during acute care. Head-up positioning and murottal therapy are commonly used supportive interventions in nursing practice, but evidence regarding their combined effects remains limited.

This study aims to evaluate the effects of a combination of a 30-degree head-up position and murottal therapy on blood pressure, pulse rate, respiratory rate, pain degree, and projectile vomiting in stroke patients. The study involves stroke patients receiving standard medical and nursing care, with the addition of the combined intervention as part of supportive nursing management.

The head-up position will be applied at a 30-degree angle, while murottal therapy will be delivered through 30-minute audio recitation during for 3 days. Physiological parameters and symptom outcomes will be measured before and after the intervention according to the study protocol. The findings of this study are expected to contribute evidence for the use of simple, non-pharmacological nursing interventions to improve comfort and physiological responses in stroke patients.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Head Up
  • Murottal Therapy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients with a medical diagnosis of stroke (hemorrhagic and non-hemorrhagic).
  2. Patients with systolic blood pressure above 150 mmHg.
  3. Somnolence (GCS ≥ 9).
  4. Muslim.
  5. Patients without hearing impairment.
  6. Willingness to participate and sign .

Exclusion criteria

Exclusion criteria :

  1. Patients who are non-Muslim.
  2. Patients with decreased consciousness (GCS \< 9).
  3. Patients with heart problems.
  4. Patients with psychiatric disorders.
  5. Patients receiving sedative therapy during the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
112 participants (estimated)

Study arms

  • Experimental
    Combination of 30-Degree Head-Up Positioning and Murottal Therapy

    Participants receive a combination of 30-degree head-up positioning and murottal therapy in addition to standard nursing care during the intervention period.

    Other: Combination of 30 Degree Head Up and Murottal Therapy

  • Active comparator
    Standard Care

    Participants receive standard nursing care according to the hospital's clinical protocol without the addition of head-up positioning or murottal therapy.

    Other: Standard Care (in control arm)

Interventions

  • OtherCombination of 30 Degree Head Up and Murottal Therapy

    Participants in this group received a combination of two non-pharmacological interventions during the study period. First, participants were positioned with their heads elevated at a 30-degree angle while lying in bed to support physiological stability, including monitoring of blood pressure, pulse rate, respiratory rate, pain level, and projectile vomiting. Second, participants listened to Quranic recitation (murottal therapy) via audio recording in a quiet environment. Both interventions were administered simultaneously. Intervention sessions lasted 30 minutes for 3 days (a consistent duration and frequency for all participants in this group). Outcomes such as vital signs, pain level, and episodes of severe vomiting were monitored before and after the intervention period.

  • OtherStandard Care (in control arm)

    Participants in this arm receive standard nursing care according to the hospital protocol without additional head-up positioning or murottal therapy. Standard care includes routine monitoring of vital signs, medication administration, and basic supportive nursing interventions.

06

What researchers measure

Primary outcomes

  1. Blood Pressure

    Change in systolic and diastolic blood pressure from baseline to after completion of the 3-day intervention.

    Time frame: Baseline and after completion of the 3-day intervention

  2. Pulse Rate

    Change in pulse rate from baseline to after completion of the 3-day intervention.

    Time frame: Baseline and after completion of the 3-day intervention

  3. Respiratory Rate

    Change in respiratory rate from baseline to after completion of the 3-day intervention

    Time frame: Baseline and after completion of the 3-day intervention

  4. Pain Degree

    Change in pain score measured using the Critical-Care Pain Observation Tool (CPOT; range 0-8), where higher scores indicate more severe pain, from baseline to after completion of the 3-day intervention.

    Time frame: Baseline and after completion of the 3-day intervention

  5. Projectile Vomiting

    Change in nausea and vomiting severity measured using the Rhodes Index of Nausea, Vomiting, and Retching (RINVR; range 0-32), where higher scores indicate more severe symptoms, from baseline to after completion of the 3-day intervention.

    Time frame: Baseline and after completion of the 3-day intervention

07

Study locations

1 site
  • Rumah Sakit Indriati Solo Baru
    Sukoharjo, Central Java 57571, Indonesia
    • Rosalia Dian Arsyta Putri, S.Kep.,Ns, M.Kep · Contactrosalia.dian@ymail.com · 02715722000
    • Kristanti Indah Saraswati, S.Kep.,Ns, M.Kes · Contactkristanti.indah@yahoo.com · 02715722000
    • Fila Diana Nurhayati, S.Kep.,Ns · Principal investigator
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2026; primary completion for May 2026, 2 months later.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 2 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 26, 2026
First posted
Feb 12, 2026
StartEst.
Mar 1, 2026
Primary completionEst.
May 31, 2026
CompletionEst.
Jun 30, 2026
Last update
Feb 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07405593
Lead sponsor
Universitas Muhammadiyah Surakarta
Responsible party
Fila Diana Nurhayati (Graduate Researcher, Universitas Muhammadiyah Surakarta) — Principal investigator
First posted
Feb 12, 2026
Start date
Mar 1, 2026 (estimated)
Primary completion
May 31, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Feb 12, 2026

Study contacts

Fila Diana Nurhayati, S.Kep.,Ns
Contact
j218250001@student.ums.ac.id
+6281228527848

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion